Status:
UNKNOWN
Role of the MSCT in Evaluation of the Congenital Cardiovascular Anomalies
Lead Sponsor:
Assiut University
Conditions:
MSCT in Congenital Cardiovascular Disease
Eligibility:
All Genders
Brief Summary
Congenital heart diseases (CHDs) are considered as the most common congenital birth defects, comprising 1% of all live births . Echocardiography remains a first-line non-invasive imaging tool for esta...
Detailed Description
The interpretation of cardiovascular structures on cardiac CT scan studies is similar to that for echocardiography, however, it is not limited by the acoustic window or operator dependent like ultraso...
Eligibility Criteria
Inclusion
- patients suffering from congenital cardiovascular diseases diagnosed either clinically or by echocardiographic examination.
Exclusion
- orthopenic patient patients with hypersensitivity to contrast , medium and poor renal function .
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04787172
Start Date
June 1 2021
End Date
September 1 2022
Last Update
March 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.